Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Science Translational Medicine|May 12, 2017
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapySean P Arlauckas, Christopher S Garris, Rainer H Kohler, et al.Nature Immunology|May 14, 2024
The aged tumor microenvironment limits T cell control of cancerAlex C Y Chen, Sneha Jaiswal, Daniela Martinez, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2010
Increased targeting of donor switch region and IgE in Sgamma1-deficient B cellsShahram Misaghi, Christopher S Garris, Yonglian Sun, et al.Nature Immunology|October 1, 2013
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammationChristopher S Garris, Linfeng Wu, Swati Acharya, et al.The Journal of Clinical Investigation|March 17, 2025
Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallengeTingting Qin, Austin K Mattox, Jean S Campbell, et al.Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.The Journal of Experimental Medicine|June 27, 2012
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and miceMay H Han, Deborah H Lundgren, Siddhartha Jaiswal, et al.Immunity|November 17, 2019
Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune ChallengeFriedrich Felix Hoyer, Kamila Naxerova, Maximilian J Schloss, et al.Immunity|December 20, 2025
Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunityBeatrice Zitti, Florent Duval, Pratyaksha Wirapati, et al.Pageof 3